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ABSTRACT the Skindex-29 instrument, which is intended for mea-
suring the influence of skin diseases on quality of life, was devel-
oped and validated in several languages. However, a Serbian trans-
lation of the instrument is not available. the aim of this study was 
to translate the Skindex-29 from english to Serbian, to make neces-
sary cultural adaptations, and to test its psychometric properties in 
a sample of outpatients with various skin diseases. the Skindex-29 
was translated and adapted according to internationally accepted 
guidelines and then tested on a sample of Serbian outpatients with 
various skin diseases. internal consistency was checked through cal-
culation of Cronbach’s alpha and interclass Correlation Coefficient 
for the instrument’s domains. the criterion validity of the translation 
was tested by correlating scores of domains with scores on the Ser-
bian version of Dermatological life Quality index (DlQi).Validity of 
the construct was tested through comparison of the domains scores 
in groups of patients with different skin diseases. Fifty-three patients 
(18.6%) suffered from acne vulgaris, 48 (16.8%) from verrucae vul-
gares, 40 (14.0%) from psoriasis, 34 (11.9%) from an undetermined 
type of mild dermatitis, 20 (7.0%) from venous ulcers, 19 (6.7%) from 
eczema, and 71 (24.9%) from other skin diseases. the Serbian transla-
tion of Skindex-29 showed good internal consistency: Cronbach’s al-
pha for emotional, Symptoms, and Functioning domains was 0.885, 
0.752, and 0.901, respectively. Validity of the instrument in all as-
pects (criterion, content, and construct validity) was satisfactory, yet 
the Symptoms domain could not discriminate well between more 
and less severe skin diseases. the Serbian translation of Skindex-29 
appears to be a reliable and valid specific instrument for measuring 
the adverse influence of skin diseases on quality of life.
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INTRODUCTION
Measuring quality of life in patients with skin dis-
eases is important in clinical practice for the evalua-
tion of disease progression and treatment effects (1-
5). One of the instruments for measuring quality of 
life in patients with skin disease is Skindex-29, devel-
oped by Chren and associates from the original 61-
item questionnaire (6). the questions (items) of this 
instrument ask a patient how often (never, Rarely, 
Sometimes, Often, All the time) during the previous 
four weeks he or she had felt the effect which is de-
scribed. the responses are scored 0, 25, 50, 75, and 
100, respectively. Skindex-29 has three domains: the 
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emotional domain (10 items: 3, 6, 9, 12, 13, 15, 21, 23, 
26, and 28), the Symptoms domain (7 items: 1, 7, 10, 
16, 19, 24, 27), and the Functioning domain (12 items: 
2, 4, 5, 8, 11, 14, 17, 20, 22, 25, 29, 30). the results are 
reported for each of the domains separately, as the 
average of a patient’s responses to the questions 
which are within a domain (7,8). Currently, there are 
no available Serbian translations with trans-cultural 
adaptations of Skindex-29 instrument, so researchers 
and clinicians in Serbia cannot use it.
the aim of our study was to translate Skindex-29 
from english to Serbian, to make necessary cultural 
adaptations, and to test its psychometric properties 
in a sample of outpatients with various skin diseases.
PATIENTS AND METHODS
Patients
the study included outpatients of the Dermatol-
ogy Clinic at the Clinical Center in Kragujevac, Serbia, 
who consecutively visited dermatology specialists 
from February to June 2016 with various complaints. 
the following patients were excluded from the study: 
patients with malignant skin tumors, those younger 
than 18 years of age, pregnant women, patients with 
cognitive disorders, patients with moderate or severe 
heart, liver, or kidney failure, those with chronic pain 
syndromes, and patients with substance abuse. 
the study was approved by the ethics Commit-
tee of the Kragujevac Clinical Center. the study pro-
cedures were in accordance with the 1975 Helsinki 
Declaration as revised in 1983.
Methods
Translation and adaptation of the original 
Skindex-29
Permission for translation and adaptation of Skin-
dex-29 was obtained from the Mapi Research institute, 
lyon, France, which holds rights to the questionnaire 
that was made by Professor Mary-Margaret Chren, 
University of California, San Francisco, USA. the trans-
lation and adaptation of the Skindex-29 was done ac-
cording to iSPOR guidelines (9). the original scale was 
first translated to Serbian by two independent trans-
lators, J. J. from the Faculty of Philology, University of 
Kragujevac, and A. S., Faculty of Philology, University 
of Belgrade, Serbia. they translated the scale inde-
pendently of each other, and the translations were 
then harmonized to one Serbian version at the meet-
ing of the study investigators with the translators. the 
harmonized Serbian version was then translated back 
to english by Z. F., a native english speaker. When 
translating back to english, he was not aware of the 
original english version of the Skindex-29. the back-
translation to english was then compared with the 
original english version, and the final Serbian version 
of the Skindex-29 was agreed on. it was then tested 
on 10 dermatology patients (at the Clinical Center in 
Kragujevac, Serbia) for clarity and comprehension. A 
few minor changes were made to the pilot version, 
and then final Serbian version of the Skindex-29 was 
copied and prepared for psychometric testing. 
Data recording
the patients completed the Serbian version of 
Skindex-29 and the Serbian version of the Dermato-
logical life Quality index (DlQi) at the Clinical Center, 
after their encounter with the dermatology specialists 
who administered the questionnaires. Permission for 
use of the Serbian version of DlQi was obtained from 
Professor A.Y. Finlay and Dr G.K. Khan, Department 
of Dermatology, School of Medicine, Cardiff Univer-
sity, United Kingdom. After completing the question-
naires, the patients returned them to the physicians. 
the dermatologists wrote down the demographic 
and clinical characteristics of the patients during the 
encounter, using a purpose-built checklist. then next 
encounter with the patients was set for two weeks, 
when they were once again given the questionnaire 
to test for temporal stability. 
Table 1. internal consistency of the Skindex-29 domains (Cronbach’s alpha values and intraclass correlation 
coefficients)
Emotional domain  
(items 3, 6, 9, 12, 13, 15, 
21, 23, 26, and 28)
Symptoms domain  
(items 1, 7, 10, 16, 19, 24, 27),
Functioning domain  
(items 2, 4, 5, 8, 11, 14, 17, 20, 
















First rating 0.885 0.435* 0.752 0.303* 0.901 0.432*
Second rating 0.898 0.468* 0.789 0.348* 0.922 0.498*
* significant at P<0.001
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Statistics
the reliability of the Skindex-29 questionnaire 
was tested by measuring the internal consistency of 
the domains through calculation of Cronbach’s alpha. 
Content validity of the translation was assessed by 
the three-member committee composed of one pro-
fessor of dermatology, one lecturer in dermatology, 
and one dermatology specialist. Criterion validity of 
the Serbian version of Skindex-29 was tested by cor-
relation of its domain scores with the DlQi score (cal-
culating Spearman’s rank correlation). Construct va-
lidity of the translation was tested by comparison of 
domain scores in patients with different dermatologi-
cal diseases by means of the Mann-Whitney U test.
All calculations in this study were performed us-
ing SPSS software, version 18. the level of significance 
was set to P<0.05.
RESULTS
Completing the questionnaires
in total, 301 patients completed the question-
naires at the first encounter, and 285 (94.7%) of them 
completed the same questionnaires again at the sec-
ond encounter with the dermatology specialist. the 
average duration of questionnaire completion was 
less than 10 minutes, and the patients did not com-
plain about any difficulties. All patients answered to 
each of the questions in the questionnaires. there-
fore, the answers of all 285 patients were included in 
the statistical calculations of reliability and validity.
Patient characteristics
 
 there were 200 women (70.2%) and 85 men 
(29.8%) in our study, all of Caucasian origin. the mean 
age was 42, 46±20 (mean ± Standard Deviation), 43 
years. Among our patients, 53 (18.6%) suffered from 
acne vulgaris, 48 (16.8%) from verrucae vulgaris, 40 
(14.0%) from psoriasis, 34 (11.9%) from an undeter-
mined type of mild dermatitis, 20 (7.0%) from venous 
ulcers, 19 (6.7%) from eczema, and 71 (24.9%) from 
other skin diseases (acne rosacea, urticaria, keratosis, 
tinea corporis or pedis, scabies, etc.). Average dura-




 the Serbian version of Skindex-29 showed satis-
factory internal consistency in all three domains since 
Cronbach’s alpha was above 0.7 and the intraclass 
correlation coefficient was significant in all three do-
mains (table 1). However, the Symptoms domain was 
the least consistent. the translated Skindex-29 ques-
tionnaire showed excellent temporal stability (test-
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Table 2. testing criterion validity: the correlations between ratings in the domain scores of the instrument 
and ratings on the Dermatological life Quality index (DlQi)
Score DLQI, 1st rating DLQI, 2nd rating
emotional domain of Skindex-29, 1st rating 0.581* 0.374*
Symptoms domain of Skindex-29, 1st rating 0.501* 0.223*
Functioning domain of Skindex-29, 1st rating 0.554* 0.399*
emotional domain of Skindex-29, 2nd rating 0.336* 0.481*
Symptoms domain of Skindex-29, 2nd rating 0.206* 0.258*
Functioning domain of Skindex-29, 2nd rating 0.329* 0.412*
* all values of Spearman’s correlation coefficients in the table are significant (P<0.001).
Table 3. Mean values of domain scores in the translation of Skindex-29 to Serbian according to the main 
skin disease types
Skin disease Emotional domain 
(items 3, 6, 9, 12, 13, 15, 
21, 23, 26 and 28)
Symptoms domain 
(items 1, 7, 10, 16, 19, 
24, 27),
Functioning domain 
(items 2, 4, 5, 8, 11, 14, 
17, 20, 22, 25, 29, 30)
Acne vulgaris (n=53) 36.4±19.2 30.1±18.4 15.7±18.2
Psoriasis (n=40) 43.4±23.7 27.1±20.8 19.0±21.3
Verrucae vulgaris (n=48) 10.3±8.9 24.6±14.0 4.7±6.3
Undetermined type of mild 
dermatitis (n=34)
12.3±13.2 26.5±11.6 8.8±8.1
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retest reliability), since values of both Cronbach’s 
alpha and intraclass correlation coefficient slightly 
increased in the second rating (table 1). 
Validity
 
 Content validity. Content validity of the transla-
tion was assessed by the three-member committee 
through comparison of the translation to Serbian with 
the original Skindex-29. the committee suggested 
several small changes to the translation, which were 
accepted and implemented by the investigators. 
Criterion validity. the scores on all three do-
mains of Skindex-29 from both ratings correlated sig-
nificantly and positively with the DlQi scores in both 
ratings (table 2). this result was expected, since both 
Skindex-29 and DlQi rate the extent of impairment 
of quality of life by skin diseases. However, the cor-
relation coefficients were the lowest when scores in 
the Symptoms domain were correlated with the DlQi 
scores. 
Construct validity. the impact of skin diseases 
on quality of life according to the translated Skin-
dex-29 questionnaire was compared among several 
diagnostic groups (acne vulgaris, verrucae vulgares, 
psoriasis, and undetermined type of mild dermatitis). 
Mean values of Skindex-29 domains and their stan-
dard deviations are shown in table 3. As expected, 
the patients with more severe skin diseases, such 
as acnae vulgaris and psoriasis, scored significantly 
higher in the emotional and functioning domains. 




 the Serbian translation of Skindex-29 showed 
excellent internal consistency in the emotional and 
Functioning domains, while the Symptoms domain 
performed satisfactorily. the validity of the instru-
ment in all aspects was satisfactory, yet the Symp-
toms domain could not discriminate well between 
more and less severe skin diseases.
When compared to the original english version 
(6-8), the Serbian translation of Skindex-29 is non-in-
ferior in emotional and Functioning domains, while 
the internal consistency and discriminative validity 
of Symptoms domain were lower. this could be ex-
plained by cultural differences in coping with pain, 
since all items in the Symptoms domain refer to pain-
ful experiences with affected skin. Studies investigat-
ing quality of life in other painful conditions, such as 
lower back pain, showed both national and individ-
ual differences in coping and interpretation of pain, 
which were reflected with increased variability in rat-
ing of quality of life instruments (10,11).
translations of Skindex-29 to other languages 
showed similar reliability as the translation to Serbi-
an, and interestingly, the Symptoms domain showed 
the lowest internal consistency as in our study. in 
the Spanish and turkish version of the Skindex-29, 
Cronbach’s alpha was 0.7 and 0.76 for the Symptoms 
domain, respectively (12,13). the Symptoms domain 
also showed only moderate internal consistency in 
the Brazilian Portuguese version (14) (Cronbach’s al-
pha 0.702), while it was much higher in the Chinese 
version, like in the original version (0.85) of Skindex-
29 (15). 
Poor capacity of the Symptoms domain to dis-
criminate between more and less severe skin dis-
eases was also noted in the translation of the Skin-
dex-29 questionnaire to the Polish language (16). 
in contrast, the translation to the German language 
discriminated well between mild and moderate to 
severe diseases within the Symptoms domain, while 
the emotional domain lacked discriminative capacity 
(17). this could be explained by differences in facto-
rial structure of the domains, since certain questions 
in the translations which were originally in the Symp-
toms domain were re-allocated to the emotional do-
main and vice-versa.
the main limitation of this study was the small 
proportion of patients with very severe skin condi-
tions in the study sample, which precluded gather-
ing a complete picture about the performance of the 
Serbian translation. this limitation was caused by 
choice of patients who participated in the study (they 
were all outpatients), since their skin conditions were 
mostly mild or moderate.
CONCLUSION
the Serbian translation of Skindex-29 appears to 
be a reliable and valid specific instrument for measur-
ing adverse influence of skin diseases on quality of 
life. Further studies are necessary to confirm the use-
fulness of this instrument in Serbian patients suffer-
ing from more severe forms of skin diseases.
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